Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Combination Therapy with LGX818 and MEK162 for Melanoma
Recruiting2 awardsPhase 3
Orange, California
This trial is studying the combination of LGX818 and MEK162 compared to LGX818 or vemurafenib alone to see if it is more effective in treating patients with melanoma that has spread or cannot be removed by surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.